Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors

Andrew B. Lassman, Khê Hoang-Xuan, Mei-Yin C. Polley, Alba A. Brandes, J. Gregory Cairncross, Johan M. Kros, Lynn S. Ashby, Martin J.B. Taphoorn, Luis Souhami, Winand N.M. Dinjens, Nadia N. Laack, Mathilde C.M. Kouwenhoven, Karen L. Fink, Pim J. French, David R. Macdonald, Denis Lacombe, Minhee Won, Thierry Gorlia, Minesh P. Mehta, Martin J. van den Bent

Open source

DOI: 10.1200/jco.21.02543
Published: 2022-08-10
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.21.02543,
  title = {Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors},
  author = {Andrew B. Lassman and Khê Hoang-Xuan and Mei-Yin C. Polley and Alba A. Brandes and J. Gregory Cairncross and Johan M. Kros and Lynn S. Ashby and Martin J.B. Taphoorn and Luis Souhami and Winand N.M. Dinjens and Nadia N. Laack and Mathilde C.M. Kouwenhoven and Karen L. Fink and Pim J. French and David R. Macdonald and Denis Lacombe and Minhee Won and Thierry Gorlia and Minesh P. Mehta and Martin J. van den Bent},
  year = {2022},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco.21.02543},
  url = {https://doi.org/10.1200/jco.21.02543}
}

RIS

TY  - JOUR
TI  - Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
AU  - Andrew B. Lassman
AU  - Khê Hoang-Xuan
AU  - Mei-Yin C. Polley
AU  - Alba A. Brandes
AU  - J. Gregory Cairncross
AU  - Johan M. Kros
AU  - Lynn S. Ashby
AU  - Martin J.B. Taphoorn
AU  - Luis Souhami
AU  - Winand N.M. Dinjens
AU  - Nadia N. Laack
AU  - Mathilde C.M. Kouwenhoven
AU  - Karen L. Fink
AU  - Pim J. French
AU  - David R. Macdonald
AU  - Denis Lacombe
AU  - Minhee Won
AU  - Thierry Gorlia
AU  - Minesh P. Mehta
AU  - Martin J. van den Bent
PY  - 2022
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco.21.02543
UR  - https://doi.org/10.1200/jco.21.02543
ER  -

APA

Lassman, A. B., Hoang-Xuan, K., Polley, M. C., Brandes, A. A., Cairncross, J. G., Kros, J. M., Ashby, L. S., Taphoorn, M. J., Souhami, L., Dinjens, W. N., Laack, N. N., Kouwenhoven, M. C., Fink, K. L., French, P. J., Macdonald, D. R., Lacombe, D., Won, M., Gorlia, T., Mehta, M. P., & Bent, M. J. V. D. (2022). Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. Journal of Clinical Oncology. https://doi.org/10.1200/jco.21.02543

Source records

crossref · retrieved 2026-09-27T03:40:14.364Z